Victhom's Neurobionix business unit achieves ISO 13485:2003 certification
"Achieving ISO 13485:2003 certification is an important corporate milestone for Neurobionix," said Mr. Nader Kameli, Chief Operating Officer of the Neurobionix business unit. "As all commercially available implantable devices have to be manufactured in compliance with ISO 13485 standards, this accomplishment is timely progress towards the commercialization of Neurostep (TM) in 2009," he continued. "Attaining ISO certification is another demonstration of our commitment to the quality of our products and processes. ISO certification will give our customers and business partners added confidence in our ability to develop technologically advanced products at quality standards generally associated with larger companies," he explained.
Most read news
Other news from the department politics & laws
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.